We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CHMP Recommends 15 New Medicines at December Meeting
CHMP Recommends 15 New Medicines at December Meeting
New drugs for breast cancer, leukemia, hepatitis B and myelofibrosis may be available to European patients soon, as the European Medicines Agency’s Committee for Medicinal Products for Human Use (EMA/CHMP) recommended that the agency approve 15 new drugs, including two biosimilars and four generics, at its Dec. 7-10 meeting.